I. Contraindications
According to literature, this medication is contraindicated in cases of cutaneous tuberculosis, herpes simplex, localized viral infections, chickenpox, and smallpox.
II. Warnings and Precautions
- For external use only. Avoid contact with eyes.
- Even if symptoms improve, continue treatment for tinea cruris and tinea corporis for up to 2 weeks, and for tinea pedis for up to 4 weeks. Do not use for more than 4 weeks. If there is no improvement in tinea cruris or tinea corporis after 1 week of treatment, or in tinea pedis after 2 weeks of treatment, please notify your doctor.
- Avoid using this medication on other symptoms.
- Do not apply bandages or other coverings to the treated area.
If using this medication on the groin area, use only for two weeks. If there is no improvement after two weeks, please inform your doctor and wear loose clothing. If a rash or any side effects occur, please inform your doctor immediately. Avoid sources of infection to prevent reinfection. Prolonged or improper use of topical corticosteroids can lead to rebound reactions (topical steroid withdrawal) after treatment cessation. Severe rebound reactions may extend beyond the initial treatment site and may present with dermatitis accompanied by intense redness, stinging, and burning sensations, especially on delicate skin areas such as the face and curved areas. If these symptoms reappear within days to weeks after successful treatment, a rebound reaction should be suspected. If you need to resume using topical corticosteroids, carefully assess their clinical benefits and risks, or consider alternative treatment options.
III. Important Clinical Side Effects/Adverse Reactions (Based on Literature)
- Due to the systemic absorption of local adrenaline, it easily causes an inhibitory reaction of HPA (Hypothalamic-pituitary-adrenal).
- Some patients experience side effects such as Klinefelter syndrome, hyperglycemia, and diabetes.
- Skin and subcutaneous tissue diseases – withdrawal reactions (frequency unknown): skin redness, which may spread beyond the initial treatment area, burning or stinging sensation, itching, skin desquamation, and suppuration.
